The team is recognized for extraordinary leadership in establishing the infrastructure for U.S. influence and participation in global biotechnology standards development. They filled a U.S. leadership void in ISO and created an inclusive, collaborative environment among 100+ organizations to best represent U.S. interests while promoting international cooperation. Their efforts made the complex standardization world accessible to U.S. industry and led to the development of global consensus standards that promote responsible biotechnology innovation and commercialization.